Where innovation finds its market

Accelerating revenue across the globe.

3comma is your total commercial partner. We accelerate the global commercialization of next-generation medical devices and unlock revenue across key markets to drive measurable growth and value.

Europe · Middle East · Asia Pacific · Latin AmericaOffices in Austria and the USA

No upfront cost for international commercial operations.

We offer an equity-based performance agreement that only awards us shares when we achieve our agreed upon milestones, so your capital stays where it belongs: in your product.

Our partners
Cagent VascularLucas MedicalFlowPhysixSinglePass

The core problem

Great healthcare products fail to scale internationally.

Breakthrough technology is only the beginning. Many healthcare innovators lack the infrastructure, regulatory expertise and international networks required to enter and grow in global markets.

International growth is not a product challenge. It is an execution challenge.

Market entry requires more than distribution:

  • Regulatory pathways
  • Market access
  • Physician networks
  • Commercial execution
  • Logistics and customer service
  • Clinical support
  • Long-term growth leadership
Astronaut helmet reflecting the stars, framed in the 3comma comma shape

Houston, we’ve solved a problem! Commercialization, executed with confidence.

How we work

We don’t just advise. We execute.

Traditional consultants create recommendations. Traditional distributors move products. 3comma takes on the whole route to market.

  • PathwayBuilds the commercial pathway
  • InfrastructureProvides the infrastructure
  • MarketExecutes in the market
  • Investment. 3comma Medical offers investment consultation and connections to both strategics and venture capital.
  • Global revenue. We generate global revenue with proven expertise in Europe, the Middle East, Asia Pacific, and Latin America.
  • Network. Our advantage is our strong network of trusted regional distributors and Key Opinion Leader physicians.
  • Focus. We drive early market demand, manage the full international supply chain and execute global sales and marketing, so you can focus on innovation while we handle scale and build value for an optimized exit.

Three entry points

From early-stage to global expansion, we partner with you at every step.

Every stage is a different conversation. Pick the one that matches where your company is today.

Stage 1

Clinical Stage Companies

From U.S. and global trial site selection to KOL engagement and trial management support, we help you run smarter, more efficient clinical programs.

  • U.S. and global trial site selection
  • KOL engagement
  • Trial management support
Book a Clinical Stage call

Stage 2

Pre-Commercial Companies

We support FDA and MDR submissions and reviews, provide RA/QA consultation, and offer fractional commercial leadership to shape organizational structure, drive strategic and business development initiatives, and guide operational planning.

  • FDA and MDR submissions and reviews
  • RA/QA consultation
  • Fractional commercial leadership
Book a Pre-Commercial call

Stage 3

Commercial Ready Companies

If you’re FDA-approved or CE-marked, we work with you to take your product global: executing go-to-market strategies, generating revenue and growing multi-market value. Together, we optimize channels, leverage KOL relationships and streamline operations to accelerate your path to market.

  • Go-to-market execution
  • Distributor networks and KOL relationships
  • Multi-market revenue
Book a Commercial Ready call

The 3comma Growth Engine

One partner. Complete commercial infrastructure.

International growth requires three connected capabilities. Senior commercial leadership, without building the full team too early.

Regulatory & Clinical

Navigate global markets with confidence.

  • FDA and CE processes
  • MDR and international regulatory requirements
  • Clinical pathway guidance
  • Market access support
  • Notified body communication
  • EU, UK and CH representative handling

Strategic Investment

Structured around long-term value creation.

  • Lower upfront burden for partner companies
  • Equity- or share-based participation
  • Milestone-driven cooperation
  • Optional additional investment where strategically relevant
  • Success linked to growth, revenue and potential exit value

Commercialization

From market entry to market leadership.

  • Distribution partner networks
  • Sales execution
  • Logistics and warehousing
  • Customer service and order processing
  • KOL and physician relationships
  • Congress presence and product awareness

Together, they turn innovation into measurable market progress.

See the partnership model

Global reach

Built on networks, not theory.

We generate global revenue with proven expertise in Europe, Asia Pacific, Latin America and the Middle East, run from our offices in Austria and the United States.

EuropeEuropean office and logistics hub in Götzendorf an der Leitha, Austria.
Middle EastMarket entry through trusted regional distribution partners.
United StatesU.S. office in East Lansing, Michigan.
Asia PacificMarket entry through trusted regional distribution partners.
Latin AmericaChannel build-up with distributors and KOL physicians.
Astronaut surfing a violet wave

The Atlantic Bridge

Ride the wave of success across the Atlantic.

We connect healthcare companies with the markets, networks and operational capabilities they need to scale internationally. Our network includes:

  • Hand-picked distribution partners
  • Physician and KOL relationships
  • Clinical specialists
  • Congress and roadshow access
  • Investor and venture connections
  • Regional market knowledge

Logistics facility

We manage all of your importation, warehousing and logistics needs.

As part of our partnership and through our logistics services in both Europe and the United States, we import, export, warehouse and process orders to send products across the world.

1,500 m²Approximate warehouse space in Austria, with capacity for an equivalent number of pallets.
400Packages processed and dispatched on an average day.
24–48 hTypical delivery time to customers in Austria and neighboring countries.
EU + USLogistics services on both sides of the Atlantic.

Build global reach without building everything yourself.

  • Expensive international office structures
  • Full commercial teams in every market
  • 3PL and warehousing complexity
  • Travel-heavy market development
  • Fragmented local vendor management
Lower complexityFaster executionReduced risk

Partnership model

Our path to market success.

You no longer need to raise or allocate funding for international commercial operations. We are only awarded shares when we achieve the milestones we agreed on together.

A larger exit valuation, a larger return on your investment.

Talk through the model
  1. 1

    We connect and learn about each other

    Through initial in-person or virtual meetings we learn about your vision and describe how 3comma can help you get to your destination.

  2. 2

    We set strategic goals

    By understanding your products, leadership and investor partners, we design a plan that is specific and measurable to achieve financial goals in a time bound manner.

  3. 3

    We partner up and begin the work

    We sign an equity-based performance agreement that allows us to execute our global commercial strategy and only awards us shares when we achieve our agreed upon milestones.

  4. 4

    We create unrealized revenue streams and build value

    You no longer need to raise or allocate funding for international commercial operations, as 3comma will manage those functions for you.

  5. 5

    We exit and we win

    By increasing revenue, we increase your valuation and attractiveness to potential acquirers: a larger exit valuation and a larger return on your investment.

Our partners

The companies we already carry into new markets.

Medical device companies that trust 3comma with their international commercial operations.

Our team of industry experts

The crew that has scaled MedTech internationally.

We bring your next generation medical devices to the global marketplace and increase your company’s value by creating unrealized revenue streams across multiple geographies.

Portrait of Marc Paris

Marc Paris

Managing Director

25 years in medical devices, with executive, commercial and general management roles at Penumbra, Medtronic and Boston Scientific.

Full profile

Marc is Managing Director of 3comma Medical. Over a 25-year career in medical devices, he has held executive leadership, commercial leadership and general management roles for companies such as Penumbra, Medtronic and Boston Scientific. Marc has also worked as an executive consultant for several medical device startups. Early in his career, he gained valuable experience at GE Capital and Ford Motor Company. Marc holds an MBA in Organizational Management from Wayne State University and a BS in Packaging Engineering from Michigan State University.

Portrait of Chris Nemeth

Chris Nemeth

Board of Directors

International commercial leadership across EMEA, APAC and LATAM.

Full profile

Christopher “Chris” Nemeth is Managing Partner and Co-Founder of 3comma Medical, with over 14 years of experience in medical device sales, commercial leadership and general management. He helps MedTech companies develop strategic partnerships and expand internationally, and supports Artiria Medical as Head of Commercial Affairs. Previously, Chris led international commercial operations across EMEA, APAC and LATAM at Q’Apel Medical and held sales and leadership roles at Penumbra, Abbott Cardiovascular and Boston Scientific. He holds a BSc in Biomedical Engineering from FH Technikum Vienna and a Diploma in Business Communication from Schule des Sprechens Vienna.

Portrait of James Pray

James Pray

Board of Directors

Former President of Penumbra and architect of its international expansion.

Full profile

Jim serves as a Board Advisor for 3comma Medical. He is the former President of Penumbra, Inc., where he helped build the organization from its earliest stages. He was the architect of Penumbra’s international organization, which accounted for over $300MM of Penumbra’s $1B market value when it went public in 2015. At his departure in 2021, Penumbra was doing business in 100+ countries, utilizing 80+ distribution partners globally. Before Penumbra, Jim held executive roles at Target Therapeutics and Boston Scientific. Today, he is active in multiple healthcare venture capital funds. Jim holds a BS and MS in Biomedical Engineering from the University of Minnesota.

Let’s partner up

From innovation to the dawn of international success.

Let’s partner up and conquer international markets. Tell us where your company stands today and we will take the conversation from there.

European office

3comma Medical GmbH
Birkenstraße 38
2434 Götzendorf an der Leitha
Austria

United States office

3comma Medical USA
East Lansing, Michigan
USA

Direct lines

office@3commamedical.com

EU office +43 664 4160890

US office +1 517 256 6605